SCHEMBL23837494

SCHEMBL23837494

CCCC(=O)N[C@H]1Cc2cc(Cl)cc(C(=O)OCOC(=O)C(C)(C)C)c2OB1N=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17347692 0.89 MTNR1A (0.30) —
SCHEMBL23837469 0.83 — —
SCHEMBL17347675 0.82 KDM4E (0.31) —
SCHEMBL23129957 0.82 KDM4E (0.31) —
SCHEMBL23130196 0.81 PRKCB (0.32) —
SCHEMBL17347755 0.81 PRKCB (0.32) —
SCHEMBL23837457 0.79 MTNR1B (0.36) —
SCHEMBL23837395 0.79 — —
SCHEMBL23129964 0.79 PARP1 (0.30) —
SCHEMBL17347711 0.79 PARP1 (0.30) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3882252-A1 BETA-LACTAMASE INHIBITORS Venatorx Pharmaceuticals, Inc. (US) 2021-09-22 — — EP disclosed
Send feedback